Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

TORRENT PHARMA vs GLENMARK PHARMA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    TORRENT PHARMA GLENMARK PHARMA TORRENT PHARMA/
GLENMARK PHARMA
 
P/E (TTM) x 56.9 -31.3 - View Chart
P/BV x 13.7 2.8 481.5% View Chart
Dividend Yield % 0.9 0.3 334.4%  

Financials

 TORRENT PHARMA   GLENMARK PHARMA
EQUITY SHARE DATA
    TORRENT PHARMA
Mar-23
GLENMARK PHARMA
Mar-23
TORRENT PHARMA/
GLENMARK PHARMA
5-Yr Chart
Click to enlarge
High Rs1,723487 353.6%   
Low Rs1,243349 356.1%   
Sales per share (Unadj.) Rs284.2460.4 61.7%  
Earnings per share (Unadj.) Rs36.813.4 275.1%  
Cash flow per share (Unadj.) Rs57.735.0 164.6%  
Dividends per share (Unadj.) Rs22.002.50 880.0%  
Avg Dividend yield %1.50.6 248.1%  
Book value per share (Unadj.) Rs183.1335.1 54.6%  
Shares outstanding (eoy) m338.45282.17 119.9%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x5.20.9 574.4%   
Avg P/E ratio x40.331.3 128.9%  
P/CF ratio (eoy) x25.711.9 215.5%  
Price / Book Value ratio x8.11.2 649.0%  
Dividend payout %59.818.7 319.9%   
Avg Mkt Cap Rs m501,779117,953 425.4%   
No. of employees `000NANA-   
Total wages/salary Rs m16,77727,810 60.3%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m96,202129,901 74.1%  
Other income Rs m6323,168 20.0%   
Total revenues Rs m96,834133,069 72.8%   
Gross profit Rs m28,24015,125 186.7%  
Depreciation Rs m7,0666,113 115.6%   
Interest Rs m3,3343,496 95.4%   
Profit before tax Rs m18,4728,685 212.7%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m6,0194,911 122.6%   
Profit after tax Rs m12,4523,774 329.9%  
Gross profit margin %29.411.6 252.1%  
Effective tax rate %32.656.5 57.6%   
Net profit margin %12.92.9 445.5%  
BALANCE SHEET DATA
Current assets Rs m53,13798,737 53.8%   
Current liabilities Rs m54,47350,455 108.0%   
Net working cap to sales %-1.437.2 -3.7%  
Current ratio x1.02.0 49.8%  
Inventory Days Days157 231.2%  
Debtors Days Days7115 6.4%  
Net fixed assets Rs m91,39076,920 118.8%   
Share capital Rs m1,692282 599.7%   
"Free" reserves Rs m60,28894,281 63.9%   
Net worth Rs m61,98194,563 65.5%   
Long term debt Rs m24,96238,521 64.8%   
Total assets Rs m144,682175,658 82.4%  
Interest coverage x6.53.5 187.7%   
Debt to equity ratio x0.40.4 98.9%  
Sales to assets ratio x0.70.7 89.9%   
Return on assets %10.94.1 263.6%  
Return on equity %20.14.0 503.4%  
Return on capital %25.19.2 274.0%  
Exports to sales %21.80-   
Imports to sales %00-   
Exports (fob) Rs m20,994NA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m20,99446,464 45.2%   
Fx outflow Rs m3,73512,712 29.4%   
Net fx Rs m17,25933,751 51.1%   
CASH FLOW
From Operations Rs m23,6816,254 378.7%  
From Investments Rs m-24,153-5,285 457.0%  
From Financial Activity Rs m774-775 -99.9%  
Net Cashflow Rs m1,101325 338.9%  

Share Holding

Indian Promoters % 71.3 46.7 152.7%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 21.3 34.7 61.4%  
FIIs % 14.1 23.7 59.4%  
ADR/GDR % 0.0 0.0 -  
Free float % 28.8 53.4 53.9%  
Shareholders   69,117 209,931 32.9%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare TORRENT PHARMA With:   SUN PHARMA    DIVIS LABORATORIES    CIPLA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on Torrent Pharma vs Glenmark Pharma

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

Torrent Pharma vs Glenmark Pharma Share Price Performance

Period Torrent Pharma Glenmark Pharma S&P BSE HEALTHCARE
1-Day -1.99% -0.84% 1.18%
1-Month -3.68% 4.88% -0.75%
1-Year 62.81% 112.38% 61.82%
3-Year CAGR 25.70% 27.39% 18.16%
5-Year CAGR 21.04% 8.00% 19.79%

* Compound Annual Growth Rate

Here are more details on the Torrent Pharma share price and the Glenmark Pharma share price.

Moving on to shareholding structures...

The promoters of Torrent Pharma hold a 71.3% stake in the company. In case of Glenmark Pharma the stake stands at 46.7%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Torrent Pharma and the shareholding pattern of Glenmark Pharma.

Finally, a word on dividends...

In the most recent financial year, Torrent Pharma paid a dividend of Rs 22.0 per share. This amounted to a Dividend Payout ratio of 59.8%.

Glenmark Pharma paid Rs 2.5, and its dividend payout ratio stood at 18.7%.

You may visit here to review the dividend history of Torrent Pharma, and the dividend history of Glenmark Pharma.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.